Kurt Yoshino, M.D.
NPI 1316327059 · Obstetrics & Gynecology Physician · Honolulu, HI
Enrolled with Medicare as Practitioner - Obstetrics/Gynecology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Kurt Yoshino, M.D. is a Obstetrics & Gynecology Physician provider in Honolulu, HI (NPI 1316327059).
Provider details
- NPI number
- 1316327059
- Entity type
- Individual
- Primary specialty
- Obstetrics & Gynecology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- 20220 (HI)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
11 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
207 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 110 | $94 |
| Dxa Bone Density Measurement of Hip, Pelvis, Spine77080 | 37 | $42 |
| Injection of Drug Or Substance Under Skin Or Into Muscle96372 | 24 | $15 |
| Cervical Or Vaginal Cancer Screening; Pelvic and Clinical Breast ExaminationG0101 | 23 | $39 |
| Established Patient Office Or Other Outpatient Visit With Straightforward Medical Decision Making, If Using Time, 10 Minutes Or More99212 | 13 | $59 |
Typical Medicare-allowed amounts for these services range $15–$94 (2024). The Medicare-allowed amount is what Medicare recognizes for a service under fee-for-service — a reference figure for 2024, and not what you would be billed. Medicare Part B covers roughly an eighth of all NPIs (65+ skew); services with fewer than 11 beneficiaries are suppressed by CMS. Source: CMS Medicare Physician & Other Practitioners, by Provider & Service.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 7 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Raloxifene Hcl | 123 | 45 |
| Denosumabbrand: Prolia | 66 | 42 |
| Alendronate Sodium | 22 | — |
| Estradiol | 12 | — |
| Halobetasol Propionate | 12 | — |
| Abaloparatidebrand: Tymlos | 11 | — |
| Valacyclovir Hclbrand: Valacyclovir | 11 | — |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they include cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means , never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$659 across 30 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2015-06-08
- Last updated
- 2019-07-09
Frequently asked questions
- What is Kurt Yoshino's NPI number?
- Kurt Yoshino's National Provider Identifier (NPI) is 1316327059, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Kurt Yoshino's specialty?
- Kurt Yoshino is listed in the NPPES registry with a primary specialty of Obstetrics & Gynecology Physician (Allopathic & Osteopathic Physicians).
- Where is Kurt Yoshino located?
- Kurt Yoshino's practice location on file with NPPES is 1329 Lusitana St Ste B2, Honolulu, HI 96813-2401.
- What is Kurt Yoshino's phone number?
- The practice phone number listed in the NPPES registry for Kurt Yoshino is (808) 599-4200.
- Does Kurt Yoshino accept Medicare?
- Kurt Yoshino is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Kurt Yoshino's NPI active?
- Yes — Kurt Yoshino's NPI (1316327059) is active in the NPPES registry as of the last update on 2019-07-09.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.